TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO) - Grunwald, V; Keilholz, U; Boehm, A (Ann Oncol, 2015)
et al.